Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia von Tran, Eric, Chinnasamy, Dhanalakshmi, Yu, Zhiya, Morgan, Richard A, Lee, Chyi-Chia Richard, Restifo, Nicholas P, Rosenberg, Steven A

Volltext

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia von Haso, Waleed, Lee, Daniel W., Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pastan, Ira H., Dimitrov, Dimiter S., Morgan, Richard A., FitzGerald, David J., Barrett, David M., Wayne, Alan S., Mackall, Crystal L., Orentas, Rimas J.

Volltext

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 von ROBBINS, Paul F, MORGAN, Richard A, KAMMULA, Udai S, HUGHES, Marybeth S, RESTIFO, Nicholas P, RAFFELD, Mark, LEE, Chyi-Chia Richard, LEVY, Catherine L, LI, Yong F, EL-GAMIL, Mona, SCHWARZ, Susan L, LAURENCOT, Carolyn, FELDMAN, Steven A, ROSENBERG, Steven A, YANG, James C, SHERRY, Richard M, DUDLEY, Mark E, WUNDERLICH, John R, NAHVI, Azam V, HELMAN, Lee J, MACKALL, Crystal L

Volltext

Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry von Zheng, Zhili, Chinnasamy, Nachimuthu, Morgan, Richard A

Volltext

Adoptive cell transfer: a clinical path to effective cancer immunotherapy von Rosenberg, Steven A, Restifo, Nicholas P, Yang, James C, Morgan, Richard A, Dudley, Mark E

Volltext

AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines von Zhang, Liyang, Zuris, John A., Viswanathan, Ramya, Edelstein, Jasmine N., Turk, Rolf, Thommandru, Bernice, Rube, H. Tomas, Glenn, Steve E., Collingwood, Michael A., Bode, Nicole M., Beaudoin, Sarah F., Lele, Swarali, Scott, Sean N., Wasko, Kevin M., Sexton, Steven, Borges, Christopher M., Schubert, Mollie S., Kurgan, Gavin L., McNeill, Matthew S., Fernandez, Cecilia A., Myer, Vic E., Morgan, Richard A., Behlke, Mark A., Vakulskas, Christopher A.

Volltext

IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors von Kerkar, Sid P, Goldszmid, Romina S, Muranski, Pawel, Chinnasamy, Dhanalakshmi, Yu, Zhiya, Reger, Robert N, Leonardi, Anthony J, Morgan, Richard A, Wang, Ena, Marincola, Francesco M, Trinchieri, Giorgio, Rosenberg, Steven A, Restifo, Nicholas P

Volltext

Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors von YACHIDA, Shinichi, WHITE, Catherine M, HRUBAN, Ralph H, KLEIN, Alison P, JONES, Sian, VELCULESCU, Victor, WOLFGANG, Christopher L, LACOBUZIO-DONAHUE, Christine A, NAITO, Yoshiki, YI ZHONG, BROSNAN, Jacqueline A, MACGREGOR-DAS, Anne M, MORGAN, Richard A, SAUNDERS, Tyler, LAHERU, Daniel A, HERMAN, Joseph M

Volltext

The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes von Yang, Shicheng, Liu, Fang, Wang, Qiong J, Rosenberg, Steven A, Morgan, Richard A

Volltext

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice von Chinnasamy, Dhanalakshmi, Yu, Zhiya, Theoret, Marc R, Zhao, Yangbing, Shrimali, Rajeev K, Morgan, Richard A, Feldman, Steven A, Restifo, Nicholas P, Rosenberg, Steven A

Volltext

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor von KOCHENDERFER, James N, FELDMAN, Steven A, YANGBING ZHAO, HUI XU, BLACK, Mary A, MORGAN, Richard A, WILSON, Wyndham H, ROSENBERG, Steven A

Volltext

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes von Johnson, Laura A, Heemskerk, Bianca, Powell, Daniel J., Jr, Cohen, Cyrille J, Morgan, Richard A, Dudley, Mark E, Robbins, Paul F, Rosenberg, Steven A

Volltext

Genetic Modification of T Cells von Morgan, Richard A, Boyerinas, Benjamin

Volltext

Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy von BEARD, Rachel E, ABATE-DAGA, Daniel, ROSATI, Shannon F, ZHILI ZHENG, WUNDERLICH, John R, ROSENBERG, Steven A, MORGAN, Richard A

Volltext

Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells von Beard, Rachel E, Zheng, Zhili, Lagisetty, Kiran H, Burns, William R, Tran, Eric, Hewitt, Stephen M, Abate-Daga, Daniel, Rosati, Shannon F, Fine, Howard A, Ferrone, Soldano, Rosenberg, Steven A, Morgan, Richard A

Volltext

Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines von Zhang, Liyang, Zuris, John A., Viswanathan, Ramya, Edelstein, Jasmine N., Turk, Rolf, Thommandru, Bernice, Rube, H. Tomas, Glenn, Steve E., Collingwood, Michael A., Bode, Nicole M., Beaudoin, Sarah F., Lele, Swarali, Scott, Sean N., Wasko, Kevin M., Sexton, Steven, Borges, Christopher M., Schubert, Mollie S., Kurgan, Gavin L., McNeill, Matthew S., Fernandez, Cecilia A., Myer, Vic E., Morgan, Richard A., Behlke, Mark A., Vakulskas, Christopher A.

Volltext

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma von Raje, Noopur, Berdeja, Jesus, Lin, Yi, Siegel, David, Jagannath, Sundar, Madduri, Deepu, Liedtke, Michaela, Rosenblatt, Jacalyn, Maus, Marcela V, Turka, Ashley, Lam, Lyh-Ping, Morgan, Richard A, Friedman, Kevin, Massaro, Monica, Wang, Julie, Russotti, Greg, Yang, Zhihong, Campbell, Timothy, Hege, Kristen, Petrocca, Fabio, Quigley, M. Travis, Munshi, Nikhil, Kochenderfer, James N

Volltext

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 von Morgan, Richard A, Yang, James C, Kitano, Mio, Dudley, Mark E, Laurencot, Carolyn M, Rosenberg, Steven A

Volltext

Treating cancer with genetically engineered T cells von Park, Tristen S, Rosenberg, Steven A, Morgan, Richard A

Volltext

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response von Robbins, Paul F, Kassim, Sadik H, Tran, Thai L N, Crystal, Jessica S, Morgan, Richard A, Feldman, Steven A, Yang, James C, Dudley, Mark E, Wunderlich, John R, Sherry, Richard M, Kammula, Udai S, Hughes, Marybeth S, Restifo, Nicholas P, Raffeld, Mark, Lee, Chyi-Chia R, Li, Yong F, El-Gamil, Mona, Rosenberg, Steven A

Volltext